Currently, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been reported in almost all countries globally. No effective therapy has been documented for COVID-19, and the role of convalescent plasma therapy is unknown. In the current study, 6 patients with COVID-19 and respiratory failure received convalescent plasma a median of 21.5 days after viral shedding was first detected, all tested negative for SARS-CoV-2 RNA within 3 days after infusion, and 5 eventually died. In conclusion, convalescent plasma treatment can end SARS-CoV-2 shedding but cannot reduce the mortality rate in critically ill patients with end-stage COVID-19, and treatment should be initiated earlier.
E150Cite as: Can Urol Assoc J 2013;7:E150-E155. http://dx.doi.org/10.5489/cuaj.11163. Epub 2012 March 2. AbstractIntroduction: Impaired renal water handling in response to neonatally-induced partial unilateral ureteral obstruction (PUUO) may be associated with altered expression of cyclooxygenase (COX). The purpose of the present study was to examine whether long-term PUUO induced at birth was associated with changes of COX-2. Methods: Rats were subjected to PUUO (n = 14) or a sham operation (n = 12) within the first 48 hours of life. The rats were divided into 4 groups: (1) PUUO at 9 weeks (n = 7); (2) the sham operation at 9 weeks (n = 6); (3) PUUO at 15 weeks (n = 7); and (4) the sham operation at 15 weeks (n = 6). Urine and blood samples were collected before sacrificing the animals. Plasma potassium, creatinine and urea, as well as the osmolality and sodium of plasma and urine were tested in each sample. The expression of renal COX-1 and COX-2 was examined at 9 and 15 weeks in rats with neonatallyinduced PUUO within the first 48 hours of life by immunoblotting and immunocytochemistry. Results: PUUO caused a marked decrease in urine osmolality and a significant increase in urinary sodium of the obstructed kidney compared with the sham-operated kidney at 9 and 15 weeks. Immunoblotting analysis showed that an abundance of COX-2 in the obstructed kidney significantly increased compared with the non-obstructed kidney and sham-operated kidney at 9 weeks (p < 0.05) and 15 weeks (p < 0.05) in rats with PUUO. In contrast, COX-1 abundance in the obstructed kidney was similar to that in the non-obstructed kidney. Immunocytochemistry confirmed these findings. Conclusion: Renal COX-2 expression in the obstructed kidney is significantly altered in response to neonatally-induced PUUO. A marked increase in COX-2 indicates that it may be an important factor in reducing renal handling of sodium and water in response to PUUO. IntroductionCongenital obstructive nephropathy is the primary cause of renal insufficiency in children.1 Congenital ureteral obstruction is distinguished by the profound impairment of kidney functions.2 Previous studies have shown that unilateral ureteral complete obstruction in adult rats caused impairment of urinary concentrating ability.3,4 However, neonatal partial unilateral ureteral obstruction (PUUO) as an experimental model for congenital obstructive nephropathy is clinically much more common than complete obstruction. Wen and colleagues demonstrated that PUUO induced neonatally in rats was associated with the development of progressive hydronephrosis. 5 The rat was chosen because obstruction induced shortly after birth simulates obstruction in the last trimester in humans. In the pediatric population, obstruction at the pelvic-ureteral junction is mostly partial and congenital. Furthermore, with rats, we can obtain a sufficient number of obstructed animals to cover the large variety of responses to obstruction seen in clinical and experimental materials with respect to severity and changes in re...
Introduction: Impaired renal water handling in response to neonatally-induced partial unilateral ureteral obstruction (PUUO) may be associated with altered expression of cyclooxygenase (COX). The purpose of the present study was to examine whether long-term PUUO induced at birth was associated with changes of COX-2.Methods: Rats were subjected to PUUO (n = 14) or a sham operation (n = 12) within the first 48 hours of life. The rats were divided into 4 groups: (1) PUUO at 9 weeks (n = 7); (2) the sham operation at 9 weeks (n = 6); (3) PUUO at 15 weeks (n = 7); and (4) the sham operation at 15 weeks (n = 6). Urine and blood samples were collected before sacrificing the animals. Plasma potassium, creatinine and urea, as well as the osmolality and sodium of plasma and urine were tested in each sample. The expression of renal COX-1 and COX-2 was examined at 9 and 15 weeks in rats with neonatally inducedPUUO within the first 48 hours of life by immunoblotting and immunocytochemistry.Results: PUUO caused a marked decrease in urine osmolality and a significant increase in urinary sodium of the obstructed kidney compared with the sham-operated kidney at 9 and 15 weeks. Immunoblotting analysis showed that an abundance of COX-2 in the obstructed kidney significantly increased compared with the non-obstructed kidney and sham-operated kidney at 9 weeks (p < 0.05) and 15 weeks (p < 0.05) in rats with PUUO. In contrast, COX-1 abundance in the obstructed kidney was similar to that in the non-obstructed kidney. Immunocytochemistry confirmed these findings.Conclusion: Renal COX-2 expression in the obstructed kidney is significantly altered in response to neonatally-induced PUUO. A marked increase in COX-2 indicates that it may be an important factor in reducing renal handling of sodium and water in response to PUUO.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.